Article
Incidental findings from cancer next generation sequencing panels
19 Jul 2021
Abstract excerpt
Next-generation sequencing (NGS) technologies have facilitated multi-gene panel (MGP) testing to detect germline DNA variants in hereditary cancer patients. This sensitive technique can uncover unexpected, non-germline incidental findings indicative of mosaicism, clonal hematopoiesis (CH), or hematologic malignancies. A retrospective chart review was conducted to identify cases of incidental findings from NGS-MGP...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
